
Decoy Therapeutics Inc.
DCOYHealthcare|Biotechnology|US
$1.13
+0.01 (+0.88%)
DCF Value
$20.42
Tangible Book / Share
$8.12
Cash / Share
$15.58
Next Earnings Report
Nov 13, 2026
EPS est. -$2.59
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Oct 16, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Decoy Therapeutics Provides Third Quarter 2026 Business Update
Nov 3, 2026 · GlobeNewsWire
Decoy Therapeutics to Present at The Small Cap Showcase
Sep 30, 2026 · GlobeNewsWire
Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program
Sep 29, 2026 · PRNewsWire
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
Sep 22, 2026 · PRNewsWire
Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules
Sep 22, 2026 · PRNewsWire
SEC Filings (99)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 16, 2026 | EFFECT | DocumentIndex | |
| Oct 16, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 7, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Sep 23, 2026 | 8-K | Material event | DocumentIndex |
| Sep 15, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 4, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 4, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 24, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 17, 2026 | EFFECT | DocumentIndex | |
| Jul 17, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 15, 2026 | 8-K | Material event | DocumentIndex |
| Jul 10, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jun 29, 2026 | 8-K | Material event | DocumentIndex |
| Jun 24, 2026 | EFFECT | DocumentIndex | |
| Jun 15, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jun 5, 2026 | RW | DocumentIndex | |
| Jun 4, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 4, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 8, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 30, 2026 | 10-K/A | Annual report | DocumentIndex |
| Apr 2, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 25, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 9, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jan 8, 2026 | 8-K | Material event | DocumentIndex |
| Jan 2, 2026 | 8-K | Material event | DocumentIndex |
| Jan 2, 2026 | 8-K | Material event | DocumentIndex |
| Dec 29, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Dec 19, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Dec 19, 2025 | 8-K | Material event | DocumentIndex |
| Nov 19, 2025 | 8-K | Material event | DocumentIndex |
| Nov 18, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |